Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed May 15, 2018 · 10-Q · 45 days after period end · 0001493152-18-006922
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$1.45M | -$2.92M | -$12.26M | -$1.64M |
| EPS Diluted | -$0.33 | -$0.08 | -$0.35 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 15, 2018 · 45 d after period end
